Login with your work email address to view charts. No credit card required.
| Art Unit: | 1629 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions 544 — Organic compounds -- part of the class 532-570 series 604 — Surgery 600 — Surgery 548 — Organic compounds -- part of the class 532-570 series 128 — Surgery 206 — Special receptacle or package 702 — Data processing: measuring, calibrating, or testing 504 — Plant protecting and regulating compositions |
| Phone: | (571) 272-0575 |
| Email: | raymond.henley@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Phrmcolgy |
| Service: | 38 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 88% over 642 cases |
|---|---|
| Difficulty: | Easier |
| Difficulty Percentile: | 26th
|
With Examiner Henley, you have a 88% chance of getting an issued patent by 3 years after the first office action. Examiner Henley is an easier examiner and in the 26th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Henley, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Henley's grant rate is higher than that of Art Unit 1629 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Henley | 0.9 |
| Art Unit 1629 | 1.4 |
Examiner Henley has granted 539 of 617 cases without any applicant-requested interviews for a grant rate of 87%.
Examiner Henley has granted 23 of 25 cases with at least one applicant-requested interview for a grant rate of 92%.
With Examiner Henley, conducting an interview increases your chance of getting a patent granted by 6%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 18838986 | Morpholine-Like Monoamine Releasers | Rejection information available with a Premium Stats subscription. See our pricing. | Patented | View |
| 17627203 | Method For Treatment Of Muscular Dystrophy | Patented | View | |
| 19364654 | Methods Of Treating Disorders Using Csf1r Inhibitors | Patented | View | |
| 18258610 | Novel Cyp3a4-Specific Inhibitors And Methods Of Using Same | Abandoned | View | |
| 17888766 | Methods Of Improving Renal Function | Patented | View | |
| 18230099 | Apilimod Compositions And Methods Of Use | Patented | View | |
| 18001180 | Methods Of Treatment For Gastrointestinal Motility Disorders | Patented | View | |
| 17725976 | Early Management, Mitigation And Prevention Of Sepsis And Sepsis-Like Syndromes, Including Neo-Natal Ards Due To Infection, Injury Or Iatrogenesis | Patented | View | |
| 16280877 | Compositions And Methods For The Treatment Of Equine Protozoal Myeloencephalitis | Patented | View | |
| 18273397 | Methods And Compositions For Treating 4- Hydroxyphenylpyruvate Dioxygenase-Like (Hpdl)-Related Diseases Or Disorders | Patented | View | |
| 18006127 | Use Of Cannabidiol In The Treatment Of Seizures Associated With Rett Syndrome | Patented | View | |
| 17906229 | Methods And Compositions For Treating Acute Lung Injury And Acute Respiratory Distress Syndrome | Patented | View | |
| 18363779 | Medicaments For The Treatment Or Prevention Of Fibrotic Diseases | Abandoned | View | |
| 18257660 | Compositions And Methods Using At Least One Glycine Or Derivative Thereof And/or At Least One N-Acetylcysteine Or Derivative Thereof, And At Least One Thymol And/or Carvacrol | Patented | View | |
| 18352999 | Treatment Of Autoimmune Disease In A Patient Receiving Additionally A Beta-Blocker | Patented | View | |
| 18523609 | Methods Of Improving Renal Function | Patented | View | |
| 18267432 | Erap Inhibitors | Patented | View | |
| 17997833 | Composition For The Prevention And Treatment Of Folate And/or Vitamin B12 Deficiency Conditions, Particularly Hyperhomocysteinemia | Abandoned | View | |
| 17771172 | Compositions And Methods For Treating Macrophage Activation Syndrome | Patented | View | |
| 18166771 | Formulations And Methods Of Treating Covid-19 And Preventing Infection With Sars-Cov-2 | Abandoned | View | |
| 19094716 | Compositions And Methods Of Use For Modified Release Minoxidil | Patented | View | |
| 19079727 | Methods Of Treating Disorders Using Csf1r Inhibitors | Patented | View | |
| 17387875 | Water Soluble Compositions Comprising Purified Cannabinoids | Patented | View | |
| 19094756 | Methods For Making And Using Endoxifen | Patented | View | |
| 19228179 | Pharmaceutical Compositions Comprising Meloxicam | Patented | View | |
| 18487668 | Transdermal Delivery Formulations | Patented | View | |
| 19228565 | Pharmaceutical Compositions Comprising Meloxicam | Patented | View | |
| 19228293 | Pharmaceutical Compositions Comprising Meloxicam | Patented | View | |
| 19231124 | Pharmaceutical Compositions Comprising Meloxicam | Patented | View | |
| 18582561 | Pharmaceutical Compositions Comprising Meloxicam | Patented | View | |
| 18949037 | Methods For Providing Rapid Relief Of Motor Fluctuations In A Parkinson's Disease Patient | Patented | View | |
| 18182463 | Methods For Treating Heterotopic Ossification | Patented | View | |
| 19087148 | Methods Of Treatment | Patented | View | |
| 17792403 | Combination Of Diltiazem And Viral Polymerase Inhibitors | Patented | View | |
| 17997604 | Method For Treating Respiratory Viral Infections Comprising Administration Of Fatty Acid Compositions | Patented | View | |
| 19076811 | Methods And Systems For Treating Disease Using An Atr/chk1 Signaling Pathway Inhibitor | Patented | View | |
| 19182463 | Compounds And Combinations Thereof For Treating Neurological And Psychiatric Conditions | Patented | View | |
| 18472037 | Agent For Eliminating Senescent Cells | Abandoned | View | |
| 19187858 | Use Of Cannabinoids In The Treatment Of Epilepsy | Patented | View | |
| 19171162 | Methods Of Using Radiprodil In The Treatment Of Disorders | Patented | View | |
| 18521801 | Kinase Inhibitor Compounds And Compositions And Methods Of Use | Patented | View | |
| 18534509 | Compositions For The Treatment Of Pathogenic- And/or Chemical-Induced Lung Injury And For The Treatment Of Cancer And Methods Of Using Same | Patented | View | |
| 18001142 | Methods And Pharmaceutical Compositions For The Treatment Of Chronic Kidney Disease | Abandoned | View | |
| 17761717 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (Prmt5) | Patented | View | |
| 18350103 | Crystalline 5-Methoxy-N,n-Diallyltryptamine Compounds | Patented | View | |
| 17413227 | Methods For Treating Heterotopic Ossification | Abandoned | View | |
| 18488324 | Anesthetic Composition And Method Of Anesthetizing The Eye | Patented | View | |
| 18544561 | 1'-Cyano Nucleoside Analogs And Uses Thereof | Patented | View | |
| 19050547 | Treatment For Heart Failure With Preserved Ejection Fraction With Guanethidine And Guanadrel | Patented | View | |
| 17490433 | Chemical Compositions And Methods Of Use | Patented | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.